vs

Side-by-side financial comparison of GCM Grosvenor Inc. (GCMG) and NEOGENOMICS INC (NEO). Click either name above to swap in a different company.

NEOGENOMICS INC is the larger business by last-quarter revenue ($186.7M vs $177.1M, roughly 1.1× GCM Grosvenor Inc.). GCM Grosvenor Inc. runs the higher net margin — 32.8% vs -57.9%, a 90.7% gap on every dollar of revenue. On growth, NEOGENOMICS INC posted the faster year-over-year revenue change (11.1% vs 7.2%). Over the past eight quarters, GCM Grosvenor Inc.'s revenue compounded faster (27.5% CAGR vs 6.5%).

GCM Grosvenor is an American alternative asset management firm, with approximately $76 billion in assets under management and approximately 530 professionals as of 2023.

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

GCMG vs NEO — Head-to-Head

Bigger by revenue
NEO
NEO
1.1× larger
NEO
$186.7M
$177.1M
GCMG
Growing faster (revenue YoY)
NEO
NEO
+3.9% gap
NEO
11.1%
7.2%
GCMG
Higher net margin
GCMG
GCMG
90.7% more per $
GCMG
32.8%
-57.9%
NEO
Faster 2-yr revenue CAGR
GCMG
GCMG
Annualised
GCMG
27.5%
6.5%
NEO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
GCMG
GCMG
NEO
NEO
Revenue
$177.1M
$186.7M
Net Profit
$58.2M
$-108.0M
Gross Margin
43.3%
Operating Margin
30.9%
46.9%
Net Margin
32.8%
-57.9%
Revenue YoY
7.2%
11.1%
Net Profit YoY
149.2%
42.0%
EPS (diluted)
$0.23
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GCMG
GCMG
NEO
NEO
Q1 26
$186.7M
Q4 25
$177.1M
$190.2M
Q3 25
$135.0M
$187.8M
Q2 25
$119.7M
$181.3M
Q1 25
$125.8M
$168.0M
Q4 24
$165.3M
$172.0M
Q3 24
$122.9M
$167.8M
Q2 24
$117.0M
$164.5M
Net Profit
GCMG
GCMG
NEO
NEO
Q1 26
$-108.0M
Q4 25
$58.2M
Q3 25
$10.5M
$-27.1M
Q2 25
$15.4M
$-45.1M
Q1 25
$463.0K
$-25.9M
Q4 24
$7.6M
Q3 24
$4.2M
$-17.7M
Q2 24
$4.8M
$-18.6M
Gross Margin
GCMG
GCMG
NEO
NEO
Q1 26
43.3%
Q4 25
43.8%
Q3 25
42.8%
Q2 25
42.6%
Q1 25
43.6%
Q4 24
44.9%
Q3 24
44.6%
Q2 24
44.1%
Operating Margin
GCMG
GCMG
NEO
NEO
Q1 26
46.9%
Q4 25
30.9%
-7.1%
Q3 25
32.7%
-14.4%
Q2 25
16.1%
-26.3%
Q1 25
12.2%
-16.6%
Q4 24
26.4%
-10.7%
Q3 24
20.3%
-12.6%
Q2 24
17.8%
-13.3%
Net Margin
GCMG
GCMG
NEO
NEO
Q1 26
-57.9%
Q4 25
32.8%
Q3 25
7.8%
-14.4%
Q2 25
12.9%
-24.9%
Q1 25
0.4%
-15.4%
Q4 24
4.6%
Q3 24
3.4%
-10.5%
Q2 24
4.1%
-11.3%
EPS (diluted)
GCMG
GCMG
NEO
NEO
Q1 26
$-0.13
Q4 25
$0.23
Q3 25
$0.16
Q2 25
$0.05
Q1 25
$-0.02
Q4 24
$0.09
Q3 24
$0.03
Q2 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GCMG
GCMG
NEO
NEO
Cash + ST InvestmentsLiquidity on hand
$242.1M
$146.1M
Total DebtLower is stronger
$428.4M
Stockholders' EquityBook value
$27.0M
$828.8M
Total Assets
$813.8M
$1.3B
Debt / EquityLower = less leverage
15.87×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GCMG
GCMG
NEO
NEO
Q1 26
$146.1M
Q4 25
$242.1M
$159.6M
Q3 25
$182.7M
$164.1M
Q2 25
$136.3M
$154.7M
Q1 25
$94.5M
$346.2M
Q4 24
$89.5M
$367.0M
Q3 24
$98.4M
$362.0M
Q2 24
$73.9M
$355.1M
Total Debt
GCMG
GCMG
NEO
NEO
Q1 26
Q4 25
$428.4M
$341.9M
Q3 25
$429.3M
Q2 25
$430.2M
Q1 25
$431.1M
Q4 24
$432.0M
$541.1M
Q3 24
$432.9M
Q2 24
$433.8M
Stockholders' Equity
GCMG
GCMG
NEO
NEO
Q1 26
$828.8M
Q4 25
$27.0M
$836.6M
Q3 25
$-7.4M
$838.3M
Q2 25
$-12.3M
$854.0M
Q1 25
$-28.3M
$888.3M
Q4 24
$-27.6M
$902.3M
Q3 24
$-31.9M
$908.2M
Q2 24
$-28.5M
$915.9M
Total Assets
GCMG
GCMG
NEO
NEO
Q1 26
$1.3B
Q4 25
$813.8M
$1.4B
Q3 25
$685.9M
$1.4B
Q2 25
$636.9M
$1.4B
Q1 25
$579.8M
$1.6B
Q4 24
$612.7M
$1.6B
Q3 24
$575.0M
$1.6B
Q2 24
$543.9M
$1.6B
Debt / Equity
GCMG
GCMG
NEO
NEO
Q1 26
Q4 25
15.87×
0.41×
Q3 25
Q2 25
Q1 25
Q4 24
0.60×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GCMG
GCMG
NEO
NEO
Operating Cash FlowLast quarter
$183.5M
$-8.1M
Free Cash FlowOCF − Capex
$175.0M
FCF MarginFCF / Revenue
98.8%
Capex IntensityCapex / Revenue
4.8%
Cash ConversionOCF / Net Profit
3.16×
TTM Free Cash FlowTrailing 4 quarters
$326.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GCMG
GCMG
NEO
NEO
Q1 26
$-8.1M
Q4 25
$183.5M
$1.3M
Q3 25
$79.8M
$8.9M
Q2 25
$42.0M
$20.3M
Q1 25
$33.3M
$-25.3M
Q4 24
$148.8M
$9.8M
Q3 24
$69.0M
$9.2M
Q2 24
$17.5M
$13.9M
Free Cash Flow
GCMG
GCMG
NEO
NEO
Q1 26
Q4 25
$175.0M
$-6.5M
Q3 25
$78.3M
$570.0K
Q2 25
$40.8M
$14.0M
Q1 25
$32.1M
$-29.8M
Q4 24
$132.0M
$-1.8M
Q3 24
$62.2M
$-1.6M
Q2 24
$12.8M
$814.0K
FCF Margin
GCMG
GCMG
NEO
NEO
Q1 26
Q4 25
98.8%
-3.4%
Q3 25
58.0%
0.3%
Q2 25
34.1%
7.7%
Q1 25
25.5%
-17.8%
Q4 24
79.9%
-1.0%
Q3 24
50.6%
-0.9%
Q2 24
10.9%
0.5%
Capex Intensity
GCMG
GCMG
NEO
NEO
Q1 26
Q4 25
4.8%
4.1%
Q3 25
1.1%
4.4%
Q2 25
1.0%
3.5%
Q1 25
0.9%
2.7%
Q4 24
10.1%
6.7%
Q3 24
5.5%
6.4%
Q2 24
4.0%
8.0%
Cash Conversion
GCMG
GCMG
NEO
NEO
Q1 26
Q4 25
3.16×
Q3 25
7.61×
Q2 25
2.72×
Q1 25
71.84×
Q4 24
19.54×
Q3 24
16.60×
Q2 24
3.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GCMG
GCMG

Asset Management1$108.6M61%
Management Service Incentive Performance Fees$61.7M35%
Management Service Incentive Carried Interest$5.1M3%
Service Other$1.8M1%

NEO
NEO

Segment breakdown not available.

Related Comparisons